Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2008, 2010 (127): 2893-2917.
Google Scholar
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma in a population of Japanese Americans in Hawaii. N Engl J Med. 1991, 325: 1132-1136. 10.1056/NEJM199110173251604.
Article
PubMed
CAS
Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
Article
PubMed
CAS
Google Scholar
Paton GR, Jacobs JP, Perkins FT: Chromosome changes in human diploid-cell cultures infected with Mycoplasma. Nature. 1965, 207: 43-45. 10.1038/207043a0.
Article
PubMed
CAS
Google Scholar
Chan PJ, Seraj IM, Kalugdan TH, King A: Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA. Gynecol Oncol. 1996, 63: 258-260. 10.1006/gyno.1996.0316.
Article
PubMed
CAS
Google Scholar
Kidder M, Chan PJ, Seraj IM, Patton WC, King A: Assessment of archived paraffin-embedded cervical condyloma tissues for mycoplasma-conserved DNA using sensitive PCR-ELISA. Gynecol Oncol. 1998, 71: 254-257. 10.1006/gyno.1998.5177.
Article
PubMed
CAS
Google Scholar
Barykova YA, Logunov DY, Shmarov MM, Vinarov AZ, Fiev DN, Vinarova NA, Rakovskaya IV, Baker PS, Shyshynova I, Stephenson AJ: Association of Mycoplasma hominis infection with prostate cancer. Oncotarget. 2011, 2: 289-297.
Article
PubMed Central
PubMed
Google Scholar
Huang S, Li JY, Wu J, Meng L, Shou CC: Mycoplasma infections and different human carcinomas. World J Gastroenterol. 2001, 7: 266-269.
Article
PubMed
CAS
Google Scholar
Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ: Persistent exposure to mycoplasma induces malignant transformation of human prostate cells. PLoS One. 2009, 4: e6872-10.1371/journal.pone.0006872.
Article
PubMed Central
PubMed
Google Scholar
Yang H, Qu L, Ma H, Chen L, Liu W, Liu C, Meng L, Wu J, Shou C: Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells. BMC Gastroenterol. 2010, 10: 132-10.1186/1471-230X-10-132.
Article
PubMed Central
PubMed
Google Scholar
Urbanek C, Goodison S, Chang M, Porvasnik S, Sakamoto N, Li CZ, Boehlein SK, Rosser CJ: Detection of antibodies directed at M hyorhinis p37 in the serum of men with newly diagnosed prostate cancer. BMC Cancer. 2011, 11: 233-10.1186/1471-2407-11-233.
Article
PubMed Central
PubMed
Google Scholar
Sippel KH, Robbins AH, Reutzel R, Boehlein SK, Namiki K, Goodison S, Agbandje-McKenna M, Rosser CJ, McKenna R: Structural insights into the extracytoplasmic thiamine-binding lipoprotein p37 of Mycoplasma hyorhinis. J Bacteriol. 2009, 191: 2585-2592. 10.1128/JB.01680-08.
Article
PubMed Central
PubMed
CAS
Google Scholar
Gong M, Meng L, Jiang B, Zhang J, Yang H, Wu J, Shou C: p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR. Mol Cancer Ther. 2008, 7: 530-537. 10.1158/1535-7163.MCT-07-2191.
Article
PubMed
CAS
Google Scholar
Le XF, Merchant O, Bast RC, Calin GA: The roles of MicroRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron. 2010, 3: 137-147. 10.1007/s12307-010-0037-4.
Article
PubMed Central
PubMed
CAS
Google Scholar
Weigelt B, Peterse JL, van‘t Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005, 5: 591-602. 10.1038/nrc1670.
Article
PubMed
CAS
Google Scholar
Biancoa R, Melisia D, Ciardiellob F, Tortoraa G: Key cancer cell signal transduction pathways as therapeutic targets. Eur J Cancer. 2006, 42: 290-294. 10.1016/j.ejca.2005.07.034.
Article
Google Scholar
Engelman JA, Luo J, Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006, 7: 606-619. 10.1038/nrg1879.
Article
PubMed
CAS
Google Scholar
Dummler B, Hemmings BA: Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans. 2007, 35: 231-235. 10.1042/BST0350231.
Article
PubMed
CAS
Google Scholar
Fayard E, Xue G, Parcellier A, Bozulic L, Hemmings BA: Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr Top Microbiol Immunol. 2010, 346: 31-56.
PubMed
CAS
Google Scholar
Xue G, Hemmings BA: PKB/Akt-dependent regulation of cell motility. J Natl Cancer Inst. 2013, 105: 393-404. 10.1093/jnci/djs648.
Article
PubMed
CAS
Google Scholar
Shukla S, MacLennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S: Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer. 2007, 121: 1424-1432. 10.1002/ijc.22862.
Article
PubMed
CAS
Google Scholar
O’Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL: mTOR Inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006, 66: 1500-1508. 10.1158/0008-5472.CAN-05-2925.
Article
PubMed Central
PubMed
Google Scholar
Keates S, Keates AC, Katchar K, Peek RM, Kelly CP: Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 2007, 196: 95-103. 10.1086/518440.
Article
PubMed
CAS
Google Scholar
Tabassam FH, Graham DY, Yamaoka Y: Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3β phosphorylation. Cell Microbiol. 2009, 11: 70-82. 10.1111/j.1462-5822.2008.01237.x.
Article
PubMed Central
PubMed
CAS
Google Scholar
Pehlivan M, Itirli G, Onay H, Bulut H, Koyuncuoglu M, Pehlivan S: Does Mycoplasma sp. play role in small cell lung cancer?. Lung Cancer. 2004, 45: 129-130. 10.1016/j.lungcan.2004.01.007.
Article
PubMed
Google Scholar
Hrbacek J, Urban M, Hamsikova E, Tachezy R, Eis V, Brabec M, Heracek J: Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case–control study. BMC Cancer. 2011, 11: 53-10.1186/1471-2407-11-53.
Article
PubMed Central
PubMed
CAS
Google Scholar
Dong ZW, Wan WH, Li ZP, Qiu WR, Wei SM: A monoclonal antibodies PD4 against gastric cancer cell line MGC803. Shengwu Huaxue Zazhi. 1985, 1: 52-58.
Google Scholar
Ning JY, Sun GX, Huang S, Ma H, An P, Meng L, Song SM, Wu J, Shou CC: Identification of antigens by monoclonal antibody PD4 and its expression in Escherichia coli. World J Gastroenterol. 2003, 9: 2164-2168.
Article
PubMed Central
PubMed
CAS
Google Scholar
Engelman JA, Zejnullahu K, Mitsudomi T, Hyland C, Oh Park J, Lindeman N, Gale CM, Zhao X, Christensen J, Rogers RM: Mechanisms of activating PI3K signaling in lung cancers that become resistant EGFR tyrosine kinase inhibitors: D2-07. J Thorac Oncol. 2007, 2: 396-10.1097/01.JTO.0000283263.45841.e0.
Article
Google Scholar
Courtney KD, Corcoran RB, Engelman JA: The PI3K Pathway As Drug Target in Human Cancer. J Clin Oncol. 2010, 28: 1075-1083. 10.1200/JCO.2009.25.3641.
Article
PubMed Central
PubMed
CAS
Google Scholar
Chen YT, Tan KA, Pang LY, Argyle DJ: The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention. BMC Vet Res. 2012, 8: 73-10.1186/1746-6148-8-73.
Article
PubMed Central
PubMed
Google Scholar
Sakr RA, Weigelt B, Chandarlapaty S, Andrade VP, Guerini-Rocco E, Giri D, Ng CK, Cowell CF, Rosen N, Reis-Filho JS: PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma. Clin Cancer Res. 2014, 20: 2326-2337. 10.1158/1078-0432.CCR-13-2267.
Article
PubMed Central
PubMed
CAS
Google Scholar
Rexer BN, Chanthaphaychith S, Dahlman KB, Arteaga CL: Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells. Breast Cancer Res. 2014, 16: R9-10.1186/bcr3601.
Article
PubMed Central
PubMed
Google Scholar
Toker A, Yoeli-Lerner M: Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006, 66: 3963-3966. 10.1158/0008-5472.CAN-06-0743.
Article
PubMed
CAS
Google Scholar
Schlieman MG, Fahy BN, Ramsamooj R, Beckett L, Bold RJ: Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer. 2003, 89: 2110-2115. 10.1038/sj.bjc.6601396.
Article
PubMed Central
PubMed
CAS
Google Scholar
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR: AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004, 23: 5853-5857. 10.1038/sj.onc.1207721.
Article
PubMed
CAS
Google Scholar
Lin HJ, Hsieh FC, Song H, Lin J: Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br J Cancer. 2005, 93: 1372-1381. 10.1038/sj.bjc.6602862.
Article
PubMed Central
PubMed
CAS
Google Scholar
Sarker D, Reid AH, Yap TA, De Bono JS: Targeting the PI3K/AKT pathway for the treatment of prostate cancer. Clin Cancer Res. 2009, 15: 4799-4805. 10.1158/1078-0432.CCR-08-0125.
Article
PubMed
CAS
Google Scholar
Kumar A, Rajendran V, Sethumadhavan R, Purohit R: AKT kinase pathway: a leading target in cancer research. Cancer Cell. 2003, 4: 257-262. 10.1016/S1535-6108(03)00248-4.
Article
Google Scholar
Song G, Ouyang G, Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005, 9: 59-71. 10.1111/j.1582-4934.2005.tb00337.x.
Article
PubMed
CAS
Google Scholar
Yap TA, Garrett MD, Walton MI, Raynaud F, De Bono JS, Workman P: Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol. 2008, 8: 393-412. 10.1016/j.coph.2008.08.004.
Article
PubMed
CAS
Google Scholar
Onishi K, Higuchi M, Asakura T, Masuyama N, Gotoh Y: The PI3K-Akt pathway promotes microtubule stabilization in migrating fibroblasts. Genes Cells. 2007, 12: 535-546. 10.1111/j.1365-2443.2007.01071.x.
Article
PubMed
CAS
Google Scholar
Yadav V, Denning MF: Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog. 2011, 50: 346-352. 10.1002/mc.20716.
Article
PubMed Central
PubMed
CAS
Google Scholar
Folgiero V, Bachelder RE, Bon G, Sacchi A, Falcioni R, Mercurio AM: The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function. Cancer Res. 2007, 67: 1645-1652. 10.1158/0008-5472.CAN-06-2980.
Article
PubMed
CAS
Google Scholar
Park BK, Zeng X, Glazer RI: Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res. 2001, 61: 7647-7653.
PubMed
CAS
Google Scholar
Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K, Takahashi M: Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell. 2009, 9: 389-402. 10.1016/j.devcel.2005.08.001.
Article
Google Scholar
Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J: Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 2001, 15: 1953-1962. 10.1096/fj.01-0198com.
Article
PubMed
CAS
Google Scholar
Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR: AKT activation up-regulates insulin-like growth factor receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 2001, 61: 589-593.
PubMed
CAS
Google Scholar
Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, Van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003, 63: 2172-2178.
PubMed
CAS
Google Scholar
Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2: 489-501. 10.1038/nrc839.
Article
PubMed
CAS
Google Scholar
Luo C, Wu Q, Huang XN, Sun AS, Shi JS: Ginkgo biloba leaf extract enhances levels of caspase-3 and amyloid precursor protein in normal rat hippocampus. Acta Pharmacol Sin. 2003, 24: 152-156.
PubMed
CAS
Google Scholar
Hayflick L, Stinebring WR: Intracellular growth of pleura pneumonia like organisms (PPLO) in tissue culture and in ovo. Ann N Y Acad Sci. 1960, 79: 433-449. 10.1111/j.1749-6632.1960.tb42709.x.
Article
PubMed
CAS
Google Scholar
Taylor G, Taylor-Robinson D, Slavin G: Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis. Ann Rheum Dis. 1974, 33: 376-10.1136/ard.33.4.376.
Article
PubMed Central
PubMed
CAS
Google Scholar
Caron J, Ouardani M, Dea S: Diagnosis and differentiation of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infections in pigs by PCR amplification of the p36 and p46 genes. J Clin Microbiol. 2000, 38: 1390-1396.
PubMed Central
PubMed
CAS
Google Scholar